title: Lymphadenopathic aggressive Kaposi's sarcoma in a renal transplant recipient with HLA-DR2 and HLA-DR5 antigens.
authors.forename: C
authors.initials: C
authors.lastname: Sungur
authors.forename: O
authors.initials: O
authors.lastname: Bozdogan
authors.forename: A
authors.initials: A
authors.lastname: Sungur
authors.forename: O
authors.initials: O
authors.lastname: Oymak
authors.forename: U
authors.initials: U
authors.lastname: Yasavul
authors.forename: C
authors.initials: C
authors.lastname: Turgan
authors.forename: S
authors.initials: S
authors.lastname: Caglar
mesh_terms: D000328:Adult; D015802:HLA-DR2 Antigen / Q000032:analysis*; D015805:HLA-DR5 Antigen / Q000032:analysis*; D006801:Humans; D007165:Immunosuppression Therapy / Q000009:adverse effects; D016030:Kidney Transplantation / Q000009:adverse effects* / Q000276:immunology*; D008206:Lymphatic Diseases / Q000209:etiology* / Q000276:immunology* / Q000473:pathology; D008297:Male; D012514:Sarcoma, Kaposi / Q000209:etiology* / Q000276:immunology* / Q000473:pathology
chemical_list: D015802:HLA-DR2 Antigen; D015805:HLA-DR5 Antigen